-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Veracyte, Lowers Price Target to $46

Benzinga·11/05/2026 10:34:53
Listen to the news
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $69 to $46.